Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer

INTRODUCTION: We have previously reported that tumour-specific expression of the rate-limiting enzyme, 3-hydroxy-3-methylglutharyl-coenzyme A reductase (HMG-CoAR), in the mevalonate pathway is associated with more favourable tumour parameters in breast cancer. In the present study, we examined the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgquist, Signe, Jögi, Annika, Pontén, Fredrik, Rydén, Lisa, Brennan, Donal J, Jirström, Karin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614512/
https://www.ncbi.nlm.nih.gov/pubmed/18808688
http://dx.doi.org/10.1186/bcr2146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614512/
https://www.ncbi.nlm.nih.gov/pubmed/18808688
http://dx.doi.org/10.1186/bcr2146

Ejemplares similares